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Book Review
Walsh is the author of over 500 scientific publications,The “Molecular Logic” Underlying
a member of the editorial board of numerous journals,Antibiotic Activity and Structure including Chemistry & Biology, and is the recipient of
several awards celebrating his contributions to enzy-
Antibiotics: Actions, Origins, Resistance mology and chemical biology. Perhaps one of his most
By Christopher Walsh effective qualities is his outstanding ability to communi-
Washington, D.C.: ASM Press (2003). 335 pp. $99.95 cate science to both chemists and biologists. His 1979
text entitled Enzymatic Reaction Mechanisms inspired
a generation of researchers and students from a variety
The impact of infectious diseases on human health is of backgrounds to study enzymes and their function,
dramatic and unquestionable. Prior to the twentieth cen- and this new book has the potential to impact the field
tury, the leading causes of death in the developed world of antibiotic biochemistry in a similar fashion. Both of
were the result of infection (sadly, this remains the case Walsh’s books share a focus on the concept of “molecu-
in developing nations). Consequently, in 1900 life expec- lar logic,” where molecular approaches used by organ-
tancy in the U.S. was 47 years. By the year 2000, life isms or enzymes that appear disparate at first examina-
expectancy had climbed to over 76 years, and the lead- tion are dissected to reveal common mechanisms that
ing causes of death are now heart disease and cancer are approachable using the methods of biochemistry
(www.cdc.gov). One of the principle factors in this dra- and molecular biology.
matic change over the past century was the discovery This new book is divided into five sections: (1) Intro-
and clinical use of antibiotics. It is fair to say that these duction to Antibiotics, (2) Antibiotic Targets and Classes,
molecules have completely changed our view of the (3) Antibiotic Resistance, (4) Antibiotic Biosynthesis, and
microbial world and infection, and for the most part we (5) Strategies for Discovery of New Antibiotics. Each
regard infectious agents as something we can control. section focuses on the chemistry and biology of the
This hubris, which arose from the incredible advances subject and as such will appeal to a broad cross-section
and clinical successes of the golden age of antibiotic of interests and backgrounds. There are copious
discovery (roughly 1940–1970), has eroded over the past amounts of figures and tables used to illustrate concepts
20 years. The emergence of new infections and agents and mechanisms and a few color plates. In an age of
such as Legionnaire’s disease (Legionella pneumo- PowerPoint presentations, more color figures would
phila), Lyme’s disease (Borrelia burgdorferi), AIDS (HIV), have perhaps been expected and would have been help-
and, most recently, SARS, along with the reemergence ful (as in the early days of this journal), but publication
of old infections such as tuberculosis and the growing costs likely would have been prohibitive. Perhaps this
consciousness of our vulnerability to bioweapons, have will be possible in a second edition? Each section is
contributed to an increased awareness that infectious prefaced by a short overview that outlines the scope
agents still have the potential to dramatically impact our and key elements covered in the upcoming chapters.
lives. Underlying this awareness is the inexorable march Section one is short and is appropriately entitled “In-
of antibiotic resistance. This process, driven by evolu- troduction to Antibiotics.” It reviews the concepts of
tion and fueled by the selective pressure resulting from antibiotic action, biosynthesis, and resistance and de-
the use of antibiotics in medicine and agriculture, cou- fines important nomenclature such as bacteriostatic
pled with the short generation time of microbes, is un- versus bactericidal agents. The second section on anti-
stoppable and requires continued cycles of antibiotic biotic targets and classes includes five chapters divided
discovery and implementation. by antibiotic target: cell wall, protein synthesis, DNA
Societal impression that infectious diseases were synthesis and repair, and others. An introductory chap-
largely under control by existing agents has been paral- ter reviews the major classes of antibiotics, bacterial
leled by a retreat by the pharmaceutical industry from physiology, and diseases caused by bacteria. Each sub-
directed efforts to discover new antibiotics in favor of sequent chapter in this section follows a general format
focusing their attention on other, largely chronic, dis- with an introductory section detailing necessary back-
eases. At the same time, however, there have been dra- ground knowledge in physiology and biochemistry fol-
matic advances in our understanding of antibiotic func- lowed by a discussion of the classes and mechanisms
of agents that inhibit these processes. The major ad-tion, the molecular basis of resistance, and the genetics
and biochemistry of antibiotic biosynthesis by microbes. vances in the past decade in the determination of the
atomic structures of various antibiotic targets, such asThese developments have come from diverse fields in-
cluding synthetic organic chemistry, enzymology, mac- the ribosome, frame the discussion of the effectiveness
of each of the antibiotics and their respective targetsromolecular structure, molecular microbiology and ge-
netics, and biotechnology. A new book authored by Prof. and provide a current overview of the field.
The book continues with a third section describingChristopher Walsh entitled Antibiotics: Actions, Origins,
Resistance seeks to bring together this information from antibiotic resistance, which contains four chapters. The
first chapter provides some background on resistancemultiple fields and present it in a format friendly to chem-
ists and other researchers interested in antibiotics and and the distinction between acquired versus innate re-
sistance, with emphasis on the strategies employed byinfectious disease.
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antibiotic producing organisms. This nicely introduces drug discovery, the predictability of the obsolescence
of our current crop of antimicrobial drugs ensures thatthe next three chapters on enzymatic mechanisms of
antibiotic modification, efflux protection approaches, the time will come when this area will again see a golden
age. This will require researchers with knowledge andand target modification. This is succeeded by the fourth
segment which deals with the biosynthesis of antibiotics passion for antibiotics. Perhaps this text can provide a
measure of catalysis toward this effort.by microbes and is divided into four chapters: regulation
of biosynthesis in producing organisms, polyketide as-
sembly, nonribosomal peptide biosynthesis, as well as Gerard D. Wright
aminoglycosides, peptides, coumarins, and mixed poly- Antimicrobial Research Centre
ketide and nonribosomal peptide strategies. This is a Department of Biochemistry
research area where Walsh and his colleagues have McMaster University
made a profound impact over the past decade. There 1200 Main Street
is much promise in leveraging a molecular understand- W. Hamilton, Ontario
ing of antibiotic biosynthesis in the synthesis of new Canada L8N 3Z5
antimicrobial compounds to address the challenges and
bacterial evasion strategies outlined in the third section
on antibiotic resistance. Walsh uses a number of exam-
ples, many of which are from his own research program,
to illustrate the logic of biosynthesis and the intercon-
nectedness of strategies microbes utilize to generate
antibiotics and chemical diversity.
The fifth and final portion of the book focuses on
current and future research areas and is comprised of
three chapters on targets, new molecules, and a sum-
mary chapter on the challenges of the future. The first
chapter discusses the validation and exploitation of new
targets that are emerging from the massive amounts of
information provided by efforts underway in genomics
and related disciplines and a fresh look at some old tar-
gets. The application of chemical genetics and combinato-
rial biochemistry in particular are discussed in the new
molecules chapter. This final section builds on the infor-
mation presented in the previous sections of the book.
It underlines the opportunities and challenges faced by
the scientific community in the face of a growing under-
standing that antimicrobial drug discovery and the use
of these agents requires a multidisciplinary approach
and an acceptance that the future will require new cycles
of discovery and prudent and creative use in both clinical
and agricultural contexts.
The last comprehensive text (as opposed to edited
compendium) to deal with the various aspects of antibi-
otics, their synthesis, and their action, was published in
1981 (Gale, E.F., Cundliffe, E., Reynolds, P.E., Rich-
mond, M.H., and Waring, M.J. [1981]. The Molecular
Basis of Antibiotic Action, Second Edition [London:
Wiley]). Much has changed since then. Walsh’s book
provides an exceptional overview of the contemporary
antibiotic field and integrates molecules, targets, bio-
synthesis, and resistance in a comprehensive and highly
readable fashion. This book is written to transcend the
divide between the chemistry and molecular microbiol-
ogy of infectious diseases and will appeal to researchers
of diverse backgrounds; this approach will also be of
value to senior undergraduate or graduate students and
will certainly find application in the classroom. Like his
previous effort in enzyme mechanisms, Walsh’s empha-
sis on molecular logic and the well-written prose deliv-
ered in this book will no doubt serve to inspire and
instruct a new group of researchers to find interest and
challenges in antibiotic biology and chemistry. Despite
the present timidity of the pharmaceutical sector to rees-
tablish or strengthen programs in infectious disease
